82362-50-3

Basic information

• Product Name: 4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone
• Synonyms: 4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone
• CAS NO: 82362-50-3
• Molecular Weight: 248.712
• Mol File: 82362-50-3.mol

Chemical Properties

• CAS DataBase Reference: 4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone(82362-50-3)
• EPA Substance Registry System: 4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone(82362-50-3)

Safety Data

• Hazardous Substances Data: 82362-50-3(Hazardous Substances Data)

Upstream product

• 104-83-6 1-Chloro-4-(chloromethyl)benzene 
• 3506-75-0 4-(4-chlorophenyl)butan-2-one 
• 288-32-4 1H-imidazole 
• 143327-55-3 1-bromo-4-(4-chlorophenyl)butan-2-one 
• 67085-11-4 1-[2-hydroxy-4-(4-chlorophenyl)-n-butyl]imidazole 

Downstream Products

• 150698-33-2 (2R,4S)-trans-2-(2-(4-chlorophenyl)ethyl)-2-(imidazol-1-yl)methyl-4-(p-toluenesulfonyloxy)methyl-1,3-dioxolane nitrate salt 
• 939027-89-1 (2SR,4S)-2-(1-imidazolylmethyl)-2-(2-(4-chlorophenyl)ethyl)-4-(4-methylbenzenesulfonyloxy-methyl)-1,3-dioxalane 
• 939027-90-4 (2S/R,4S)-azalanstat 
• 143393-27-5 (2S,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-[{(4-aminophenyl)thio}methyl]-1,3-dioxolane 
• 882004-55-9 (2R,4R)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)-methyl]-4-methyl-1,3-dioxalane 
• 884381-88-8 (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4-[(methylthio)methyl]-1,3-dioxolane 
• 884381-86-6 (2R,4R)-2-[2-(4-chlorophenyl)ethyl]-4-(hydroxymethyl)-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolane 
• 884381-91-3 (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-4-(fluoromethyl)-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolane 
• 884381-82-2 (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4-[(phenylsulfanyl)methyl]-1,3-dioxolane 
• 1093058-50-4 (2R,4R)-4-(aminomethyl)-2-[(1H-imidazol-1-yl)methyl]-2-[(2-phenyl)ethyl]-1,3-dioxolane 
• 1092851-91-6 (2R,4S)-4-(chloromethyl)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolane 
• 1093058-53-7 (2R,4R)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4-(methoxymethyl)-1,3-dioxolane 
• 1093058-31-1 (2R,4R)-4-(azidomethyl)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolane 
• 1093058-51-5 1-{2-[2-(4-chlorophenyl)ethyl]-4-thiocyanatomethyl-[1,3]dioxolan-2-ylmethyl}-1H-imidazole 

Relevant articles and documents

HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM

Disclosed are compounds of the general formula (1): compositions comprising an effective amount of said compounds either alone or in combination with other chemotherapeutic agents, and methods useful for treating or preventing cancer and for inhibiting tumour tissue growth. These compounds attenuate the oxidative damage associated with increased heme-oxygenase activity and can reduce cell proliferation in transformed cells. In addition, the described compounds and compositions are useful as neuroprotectants and for treating or preventing neurodegenerative disorders and other diseases of the central nervous system.

CHIRALLY PURE ISOMERS OF ITRACONAZOLE AND INHIBITORS OF LANOSTEROL 14A- DEMETHYLASE FOR USE AS ANGIOGENESIS INHIBITORS

Described herein are methods of inhibiting angiogenesis, and treating or preventing a disease or disorder (or symptoms thereof) associated with angiogenesis, wherein an anti-angiogenesis compound is administered to a subject.

Process for preparing 1,3-dioxolane derivatives

This invention provides an improved process for the preparation of compounds of formula (I): STR1 wherein: n is 0, 1 or 2; each R1 is independently halo or lower alkyl; R2 is nitro or --N(R3)R4 where R3/su